Cytomation, Inc., of Fort Collins, CO, is an engineering instrumentation firm founded in 1988 by two Australian scientists. Renamed Dakocytomation Colorado Inc, the firm is now part of the Danish firm Dako - a firms focused to cancer diagnostics through the development, manufacture and marketing of cell-based cancer diagnostics for both clinical diagnostics and research use. A key factor in ensuring patients the best treatment is to make an accurate diagnosis at an early stage. Dakos products help doctors all over the world to make more precise diagnoses of cancer patients on the basis of reliable test results. Dako aims to improve cancer diagnostics and help create higher productivity and better workflow in hospital and research laboratories. Dako therefore seeks to continuously develop and offer ever more automated and integrated diagnostic systems and products which give the pathologist and laboratory personnel better opportunities to exploit the benefits of both existing forms of treatment and the constantly increasing number of new forms of treatment. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has 40 years' experience in the development and production of reagents and antibodies.
